These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32206949)

  • 81. Prognostic Impact of Nodal Skip Metastasis in Resected Esophageal Squamous Cell Carcinoma.
    Zheng YZ; Li XQ; Liu SY
    Ann Thorac Surg; 2020 May; 109(5):1629. PubMed ID: 31400329
    [No Abstract]   [Full Text] [Related]  

  • 82. Risk-stratified clinical management of superficially invasive esophageal squamous cell carcinoma after endoscopic resection: finding the sweet spot.
    Jansen M; Bergman J
    Endoscopy; 2018 Jul; 50(7):655-656. PubMed ID: 29949821
    [No Abstract]   [Full Text] [Related]  

  • 83. Surgical Protocols for Squamous Cell Cancer of the Esophagus.
    Moreno MCF; Law S
    Methods Mol Biol; 2020; 2129():335-358. PubMed ID: 32056189
    [TBL] [Abstract][Full Text] [Related]  

  • 84. An insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma.
    Yang YS; Hu WP; Wang WP; Yuan Y; Chen LQ
    Surgery; 2019 Mar; 165(3):664-667. PubMed ID: 30193735
    [No Abstract]   [Full Text] [Related]  

  • 85. ASO Author Reflections: The Impact of Early Skeletal Muscle Loss Within 1 Week After Esophagectomy on Long-term Prognosis in Patients with Esophageal Cancer.
    Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Oct; 28(11):6388-6389. PubMed ID: 33638046
    [No Abstract]   [Full Text] [Related]  

  • 86. ASO Author Reflections: The Negative Impact of Postoperative Complications on Long-Term Outcomes After Esophagectomy: The Influence of Neoadjuvant Therapy and Future Perspectives.
    Takeuchi M; Kawakubo H; Kitagawa Y
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):725-726. PubMed ID: 31520203
    [No Abstract]   [Full Text] [Related]  

  • 87. Synchronous Resection of Parotid Metastasis With Esophagectomy: A Case Report.
    Suzuki H; Abe T; Sasaki E; Nagao T; Murashima A; Fujieda H; Higaki E; Hanai N
    In Vivo; 2021; 35(4):2337-2340. PubMed ID: 34182515
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reply to: Insufficient number of examined lymph nodes may offset the survival benefit from neoadjuvant therapy in esophageal squamous cell carcinoma.
    Franko J; McAvoy S
    Surgery; 2019 Mar; 165(3):664-667. PubMed ID: 30467040
    [No Abstract]   [Full Text] [Related]  

  • 89. ASO Author Reflections: Effectiveness of Resection of Oligometastases from Esophageal Cancer.
    Ohkura Y
    Ann Surg Oncol; 2020 Mar; 27(3):660-661. PubMed ID: 31907746
    [No Abstract]   [Full Text] [Related]  

  • 90. ASO Author Reflections: Current State of Surgical Sarcopenia in Esophageal Cancer.
    Uemura S; Shichinohe T; Hosokawa M; Hirano S
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):670-671. PubMed ID: 31372870
    [No Abstract]   [Full Text] [Related]  

  • 91. ASO Author Reflections: Margin Positivity Following Esophageal Cancer Resection is Associated with Treatment Decisions.
    Schlick CJR; Bentrem DJ
    Ann Surg Oncol; 2020 May; 27(5):1508-1509. PubMed ID: 32078715
    [No Abstract]   [Full Text] [Related]  

  • 92. Reply to "Nodal skip metastasis may undermine the predictive power of topographic pN classification in esophageal squamous cell carcinoma".
    Sugawara K; Yamashita H; Seto Y
    Surgery; 2018 Nov; 164(5):1126-1134. PubMed ID: 30025925
    [No Abstract]   [Full Text] [Related]  

  • 93. ASO Author Reflections: Evaluation of Tumor Regression After Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma-How to Do It?
    Takeda FR; Tustumi F; Cecconello I
    Ann Surg Oncol; 2020 Apr; 27(4):1248-1249. PubMed ID: 31673941
    [No Abstract]   [Full Text] [Related]  

  • 94. ASO Author Reflections: Longitudinal Nutritional Outcomes of Thoracic Duct Resection for Radical Esophagectomy.
    Fujisawa K
    Ann Surg Oncol; 2021 Dec; 28(13):8426-8427. PubMed ID: 34120265
    [No Abstract]   [Full Text] [Related]  

  • 95. ASO Author Reflections: Is Minimally Invasive Ivor-Lewis the Future of Esophagectomy?
    Naffouje SA
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):719-720. PubMed ID: 32567034
    [No Abstract]   [Full Text] [Related]  

  • 96. ASO Author Reflections: What is the Optimal Method of Digestive Reconstruction Following Pharyngolaryngectomy with Total Esophagectomy?
    Okamura A; Watanabe M; Mitani H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):824-825. PubMed ID: 32643000
    [No Abstract]   [Full Text] [Related]  

  • 97. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma.
    Ma S; Yan T; Liu D; Wang K; Wang J; Song J; Wang T; He W; Bai J; Jin L; Chen X
    Thorac Cancer; 2018 Feb; 9(2):310-315. PubMed ID: 29319236
    [TBL] [Abstract][Full Text] [Related]  

  • 98. ASO Author Reflections: The Prophets of Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Trimodality Therapy.
    Liang Z; Dragomir MP; Xi M; Chen B
    Ann Surg Oncol; 2023 Jan; 30(1):539-540. PubMed ID: 36184712
    [No Abstract]   [Full Text] [Related]  

  • 99. Prognostic power of lymph node station ratio for resected esophageal squamous cell carcinoma patients deserves additional investigation.
    Yang YS; Hu WP; Wang WP; Yuan Y; Chen LQ
    J Surg Oncol; 2018 Jul; 118(1):49. PubMed ID: 29878353
    [No Abstract]   [Full Text] [Related]  

  • 100. ASO Author Reflections: Significance of Esophageal Cancerous Stenosis: The Nutritional, Survival, and Oncological Impacts.
    Sugawara K; Fukuda T
    Ann Surg Oncol; 2023 May; 30(5):2713-2714. PubMed ID: 36512259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.